Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.75
-0.14 (-2.38%)
Nov 20, 2024, 4:00 PM EST - Market open
Abeona Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 258 | 124 | 53 | 49 | 155 | 273 | |
| Market Cap Growth | 162.66% | 134.61% | 7.07% | -68.06% | -43.37% | -20.20% | |
| Enterprise Value | 164 | 76 | 43 | -11 | 67 | 233 | |
| Last Close Price | 5.75 | 5.01 | 3.08 | 8.43 | 39.25 | 81.75 | |
| PS Ratio | - | 35.46 | 37.41 | 16.47 | 15.47 | - | |
| PB Ratio | 5.45 | 8.37 | 1.98 | 1.17 | 1.51 | 1.53 | |
| P/TBV Ratio | 5.98 | 8.37 | 1.98 | 1.21 | 2.26 | 2.49 | |
| EV/Sales Ratio | - | 21.73 | 30.43 | - | 6.68 | - | |
| Debt / Equity Ratio | 0.50 | 0.36 | 0.29 | 0.22 | 0.09 | 0.04 | |
| Asset Turnover | - | 0.05 | 0.02 | 0.03 | 0.05 | - | |
| Quick Ratio | 6.04 | 4.07 | 6.73 | 2.89 | 2.26 | 3.34 | |
| Current Ratio | 6.12 | 4.15 | 6.83 | 3.39 | 2.33 | 3.42 | |
| Return on Equity (ROE) | -209.50% | -260.60% | -114.85% | -117.22% | -59.96% | -48.82% | |
| Return on Assets (ROA) | -40.68% | -46.99% | -39.34% | -31.07% | -16.19% | -24.23% | |
| Return on Capital (ROIC) | -78.60% | -110.32% | -65.68% | -43.99% | -20.37% | -30.07% | |
| Earnings Yield | -28.34% | -43.66% | -75.04% | -171.90% | -54.45% | -27.93% | |
| FCF Yield | -20.17% | -30.09% | -82.44% | -141.30% | -23.50% | -25.31% | |
| Buyback Yield / Dilution | -93.20% | -171.96% | -99.65% | -6.24% | -84.02% | -5.95% | |
| Total Shareholder Return | -93.20% | -171.96% | -99.65% | -6.24% | -84.02% | -5.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.